FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Thursday reported first-quarter net income of $2.02 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1.61. Earnings, adjusted for one-time gains and costs, were $2.03 per share.
The results exceeded Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.89 per share.
The HIV and hepatitis C drugmaker posted revenue of $6.96 billion in the period, also surpassing Street forecasts. Seven analysts surveyed by Zacks expected $6.89 billion.
Gilead expects full-year results to range from a loss of $1.05 per share to a loss of 65 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Intel%20Corp_%20badge%20holder-by%20hasrul_rais%20via%20Shutterstock.jpg)
/Palantir%20by%20Hiroshi-Mori-Stock%20via%20Shutterstock.jpg)
/Robinhood%20app%20on%20phone%20by%20Andrew%20Neel%20via%20Unsplash.jpg)